AGM/EGMJun 3, 2026, 04:16 PM
Health Catalyst Announces 2026 Annual Meeting of Stockholders
AI Summary
Health Catalyst, Inc. has filed a Definitive Proxy Statement (DEF 14A) announcing its 2026 Annual Meeting of Stockholders, scheduled to be held virtually on July 16, 2026. The meeting agenda includes the election of two Class I directors, ratification of Ernst & Young LLP as the independent registered public accounting firm, an advisory vote on executive compensation, and a proposal to restate the Amended and Restated Certificate of Incorporation to phase out the classified board structure. The board of directors recommends a vote in favor of all proposals. Stockholders of record as of May 22, 2026, are eligible to vote.
Key Highlights
- Health Catalyst to hold 2026 Annual Meeting of Stockholders virtually on July 16, 2026.
- Proposals include election of two Class I directors, ratification of Ernst & Young LLP as auditor, advisory vote on executive compensation, and restatement of Certificate of Incorporation.
- Stockholders of record as of May 22, 2026, are entitled to vote.
- Board recommends voting FOR director nominees, auditor ratification, executive compensation approval, and Certificate of Incorporation restatement.
Price Impact
More from HCAT